Phase I study of LY2181308, an antisense oligonucleotide against survivin, in patients with advanced solid tumors

Overview of attention for article published in Cancer Chemotherapy and Pharmacology, November 2010

Altmetric Badge

Mentioned by

wikipedia: 1 Wikipedia page

Citations

dimensions_citation: 72 Dimensions

Readers on

mendeley: 37 Mendeley

Summary Wikipedia Dimensions citations

So far, Altmetric has seen 1 Wikipedia article.

LY2181308

Cited by user CitationCleanerBot on 12 Sep 2011

LY2181308 is an antisense oligonucleotide that complementarily binds to survivin mRNA and inhibits its expression in tumor tissue.